Clinical Trial Update: NOACs for Atrial Tachyarrhythmias in Congenital Heart Disease

View source ↗

Summary

An update on a trial evaluating novel oral anticoagulants for atrial tachyarrhythmias in congenital heart disease. The sponsor is AMC-UvA, and the current trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Congenital Heart Disease
• Ectopic Atrial Tachycardia

Drugs mentioned

• Novel oral anticoagulants (NOACs)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Congenital Heart Defects, Atrial Fibrillation | Status: UNKNOWN